PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Obesity-fighting drugs may reduce alcohol consumption in individuals with alcohol use disorder

2024-11-13
(Press-News.org) A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, were associated with fewer hospitalisations among individuals with alcohol use disorder, AUD. Fewer hospitalisations were observed for alcohol related causes, substance use related causes, and for physical illnesses. However, no association was observed for hospitalisations due to attempted suicide.

Effective treatments for alcohol dependence exist; however, they remain underused and are not effective, or suitable, for all patients with alcohol or substance use disorder. Previous preliminary studies in animals and humans have shown that GLP-1 agonists may significantly reduce the consumption of alcohol and other substances.

The present study examined Swedish registry data on more than 200,000 individuals who had been diagnosed with alcohol use disorder in 2006–2021. Their drug treatments and hospitalisations were followed up until the end of 2023 using the PRE2DUP method developed by the research team and a within-individual design. During the follow-up, 4,321 of the study participants were using semaglutide, and 2,509 were using liraglutide.

The use of GLP-1-agonists was associated with a significantly reduced risk of hospitalisation due to alcohol use disorder. Semaglutide was associated with a 36% lower risk, and liraglutide with a 28% lower risk of hospitalisation. Both drugs were also associated with a significantly reduced risk of hospitalisation due to any substance use disorder: semaglutide with a 32% lower risk, and liraglutide with a 22% lower risk.

The risk of hospitalisation when using GLP-1-agonists was lower than when using naltrexone, which was the most effective drug among drugs already approved for alcohol use disorder. Naltrexone was associated with a 14% lower risk of hospitalisation due to alcohol and substance use related causes.

The use of semaglutide, liraglutide and AUD drugs were all associated with fewer hospitalisations due to physical illness: semaglutide with 22% fewer, liraglutide with 21% fewer, and AUD drugs with 15% fewer hospitalisations. No statistically significant association was observed between the use of GLP-1-agonists and hospitalisations due to attempted suicide.

“The research idea stems from patient observations reporting less alcohol consumption since initiating a semaglutide drug. Similar observations have also been highlighted by scientists in international conferences, so we decided to examine this in more detail,” says Docent of Forensic Psychiatry Markku Lähteenvuo of the University of Eastern Finland and the Niuvanniemi Hospital.

“Our study suggests that besides obesity and diabetes, GLP-1-agonists may also help in the treatment of alcohol and substance use disorders; however, these findings need to be further validated in randomised controlled trials,” Lähteenvuo notes.

END


ELSE PRESS RELEASES FROM THIS DATE:

Does AI improve doctors’ diagnoses? Study puts it to the test

Does AI improve doctors’ diagnoses? Study puts it to the test
2024-11-13
With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors’ diagnoses when compared with the use of usual resources.  The study, from UVA Health’s Andrew S. Parsons, MD, MPH and colleagues, enlisted 50 physicians in family medicine, internal medicine and emergency medicine to put Chat GPT Plus to the test. Half were randomly assigned to use Chat GPT Plus to diagnose complex cases, while the other half relied on conventional methods such as medical reference sites (for example, UpToDate©) and Google. The researchers then compared the resulting ...

Extreme weather accelerates nitrate pollution in groundwater

Extreme weather accelerates nitrate pollution in groundwater
2024-11-13
Extreme weather spurred by climate change, including droughts and heavy rains, may increase the risk of nitrates from fertilizers ending up in groundwater, according to a recent study from researchers at the University of California, Davis. The study found heavy rains after a drought caused nitrates to seep 33 feet under farm fields in as little as 10 days. The study was published in Water Resources Research.  “The conventional wisdom was that it could take several weeks to years for nitrates to move from the crop root zones to reach groundwater,” said corresponding author Isaya Kisekka, a professor in the Departments ...

Burden of liver cancer attributable to hepatitis B and alcohol globally, in China, and for five sociodemographic index regions from 1990 to 2021

Burden of liver cancer attributable to hepatitis B and alcohol globally, in China, and for five sociodemographic index regions from 1990 to 2021
2024-11-13
Background and Aims Liver cancer is a digestive system malignancy that poses a significant public health challenge globally. This study aimed to analyze and compare the epidemiological trends of liver cancer attributed to hepatitis B (LCHB) and alcohol use (LCAL) over the past 32 years. Methods Data on mortality and disability-adjusted life years for LCHB and LCAL in China, globally, and across five sociodemographic index regions were obtained from the Global Burden of Disease 2021 database and comprehensively ...

Lehigh partners with North Carolina A&T to enhance flood damage mapping with AI and advanced radar

2024-11-13
One only needs to glance at the news, social media, or even just out the window to understand the devastation caused by flooding. Recent back-to-back major hurricanes have brought catastrophic rainfall that has devastated communities across the southeastern United States.  With climate change, experts predict these extreme weather events will increasingly become the norm. Among the many ways that researchers are devising strategies to protect and assist vulnerable areas, one such effort involves increasing the speed and accuracy of damage assessments. “Research ...

2024 AAAS Kavli Science Journalism Award winners named

2024-11-13
Stories on the discovery of vital fluid-transport systems in the human body are among the winners of the 2024 AAAS Kavli Science Journalism Awards. Winning journalists also did immersive stories on scientists and physicians at work – in the field, in the lab and in the emergency room.    Independent panels of science journalists select the winners of the awards, which are administered by the American Association for the Advancement of Science (AAAS) and endowed by The Kavli Foundation. There is a Gold Award ($5,000) and Silver Award ($3,500) for each of the eight categories. The global awards program drew entries ...

Collaborative of prominent academic institutions launches groundbreaking healthcare AI challenge

2024-11-13
Mass General Brigham AI is hosting the Healthcare AI Challenge, a multi-institutional virtual, interactive series of events where healthcare professionals can explore and assess the latest AI healthcare technologies in real-world healthcare scenarios. The Healthcare AI Challenge Collaborative is launching with a diverse set of healthcare institutions and their healthcare professionals, including Mass General Brigham; Emory Healthcare; the Department of Radiology at the University of Wisconsin School of Medicine and Public Health; and the Department of Radiology at the University of Washington School of Medicine. The American College of Radiology (ACR), ...

American Federation for Aging Research announces 2024 AFAR grants for junior faculty

2024-11-13
NEW YORK, NY— The American Federation for Aging Research (AFAR) is pleased to announce the recipients of its 2024 AFAR Grants for Junior Faculty. The AFAR Grants for Junior Faculty program provides up to $150,000 for a one- to two-year award to junior faculty (MDs and PhDs) to conduct research that will serve as the basis for longer term research efforts on the biology of aging. The major goal of this program is to assist in the development of the careers of early career investigators committed to pursuing careers in aging research. Selected through ...

Potential single-dose smallpox and mpox vaccine moves forward

2024-11-13
Highlights: An FDA-approved vaccine for smallpox and mpox is effective but causes side effects. The other requires multiple doses. An experimental single-dose vaccine uses the horsepox virus to harness the benefits of both strategies.  Previous studies suggest that inoculation with horsepox elicits an antibody response to mpox and provides 100% protection in animal models. New data show that the horsepox virus is significantly more attenuated, or weakened, compared to the virus used in the FDA-approved live virus vaccine.  Washington, D.C.—Vaccines that prevent smallpox and mpox come in 2 varieties. One uses a single shot of a live virus but ...

Mass General Brigham Gene and Cell Therapy Institute names Spark Grant recipients

2024-11-13
The Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and developing FDA-approved treatments, today announced four winning project groups, consisting of seven individuals, of its second annual Spark Grant program. The program was created to fund gene and cell therapy projects by Mass General Brigham investigators that demonstrate tangible advancements towards clinical applications and commercialization outcomes, including licensing, partnerships, or new company creation. A total of $1,150,000 ...

New discovery may lead to more effective treatment for cardiovascular disease

New discovery may lead to more effective treatment for cardiovascular disease
2024-11-13
CLEVELAND—Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack. In a new study, published in the journal Cell Reports, they identified an inflammation-reducing molecule—called itaconate (ITA)—that could be the foundation of a new approach to treat such a common and deadly disease.  Heart disease is the leading cause of death for ...

LAST 30 PRESS RELEASES:

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

New model of neuronal circuit provides insight on eye movement

Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies

[Press-News.org] Obesity-fighting drugs may reduce alcohol consumption in individuals with alcohol use disorder